Compare DNMX & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNMX | KRMD |
|---|---|---|
| Founded | 2025 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.4M | 216.3M |
| IPO Year | 2025 | N/A |
| Metric | DNMX | KRMD |
|---|---|---|
| Price | $9.95 | $4.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 77.0K | ★ 247.1K |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,070,637.00 |
| Revenue This Year | N/A | $24.39 |
| Revenue Next Year | N/A | $18.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.12 |
| 52 Week Low | $9.87 | $1.86 |
| 52 Week High | $9.99 | $6.61 |
| Indicator | DNMX | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 36.68 |
| Support Level | $9.95 | $4.31 |
| Resistance Level | $9.99 | $5.83 |
| Average True Range (ATR) | 0.01 | 0.31 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 50.00 | 23.84 |
Dynamix Corp III is a a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).